Advertisement GeneLink expands testing capabilities - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

GeneLink expands testing capabilities

GeneLink Biosciences, a consumer genomics biotech company, has expanded its testing capabilities through a service agreement with a nationally recognized diagnostic laboratory to process the company's single nucleotide polymorphism-based assessments.

GeneLink’s DNA assessments are based on GeneLink’s scientific research and patents and utilize GeneLink’s patented DNA Collection Kit.

In August, 2008 GeneWize Life Sciences, a wholly owned subsidiary of GeneLink, successfully launched the first direct selling industry company to focus exclusively on marketing nutritional supplements and skincare products specifically tailored to an individual’s genetic makeup.

Bernard Kasten, executive chairman of GeneLink, said: “The highly successful launch of GeneWize Life Sciences has driven significant demand for our proprietary tests and we are strategically expanding our testing capacity in order to support future growth. Our new testing partner is amongst the foremost genetic testing laboratories in the world.”